Cardiac autonomic dysregulation in acute schizophrenia

Acta Neuropsychiatrica

Volumn 25, Issue 3, 2013, Pages 155-164

  Chang, Hsin An ^a   Chang, Chuan Chia ^a   Tzeng, Nian Sheng ^a   Kuo, Terry B J ^b   Lu, Ru Band ^c   Huang, San Yuan ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

cardiac autonomic function; heart rate variability; schizophrenia

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; SCHIZOPHRENIA; STANDING; SUPINE POSITION; VAGUS TONE;

EID: 84879925162     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/acn.12014     Document Type: Article

References (56)

1. BROWN S, INSKIP H, BARRACLOUGH B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000;177:212-217
2. HENNEKENS CH, HENNEKENS AR, HOLLAR D, CASEY DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005;150:1115-1121
3. CURKENDALL SM, MO J, GLASSER DB, ROSE STANG M, JONES JK. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiatry 2004;65: 715-720
4. CARPEGGIANI C, EMDIN M, BONAGUIDI F et al. Personality traits and heart rate variability predict long-Term cardiac mortality after myocardial infarction. Eur Heart J 2005; 26:1612-1617
5. SMITH LL, KUKIELKA M, BILLMAN GE. Heart rate recovery after exercise: A predictor of ventricular fibrillation susceptibility after myocardial infarction. Am J Physiol Heart Circ Physiol 2005;288:H1763-H1769
6. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93:1043-1065
7. BOETTGER S, HOYER D, FALKENHAHN K, KAATZ M, YERAGANI VK, BAR KJ. Altered diurnal autonomic variation and reduced vagal information flow in acute schizophrenia. Clin Neurophysiol 2006;117:2715-2722
8. GALUSZKA J, OPAVSKY J, LUKL J, STEJSKAL P, ZAPLETALOVA J, SALINGER J. Short-Term spectral analysis of heart rate variability during supine-standing-supine test in patients with paroxysmal atrial fibrillation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2004;148:63-67
9. KOJECKY V, BERNATEK J, HOROWITZ M, ZEMEK S, BAKALA J, HEP A. Prevalence and determinants of delayed gastric emptying in hospitalised type 2 diabetic patients. World J Gastroenterol 2008;14:1564-1569
10. BOULTON AJ, VINIK AI, AREZZO JC et al. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care 2005;28:956-962
11. OKADA T, TOICHI M, SAKIHAMA M. Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function in schizophrenia. J Clin Psychopharmacol 2003;23:441-447
12. TOICHI M, KUBOTA Y, MURAI T et al. The influence of psychotic states on the autonomic nervous system in schizophrenia. Int J Psychophysiol 1999;31:147-154
13. RECHLIN T, CLAUS D, WEIS M. Heart rate variability in schizophrenic patients and changes of autonomic heart rate parameters during treatment with clozapine. Biol Psychiatry 1994;35:888-892
14. COHEN H, MATAR MA, KAPLAN Z, KOTLER M. Power spectral analysis of heart rate variability in psychiatry. Psychother Psychosom 1999;68:59-66
15. HENNESSY S, BILKER WB, KNAUSS JS et al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: Cohort study using administrative data. BMJ 2002; 325:1070
16. BIRKHOFER A, GEISSENDOERFER J, ALGER P et al. The deceleration capacity- A new measure of heart rate variability evaluated in patients with schizophrenia and antipsychotic treatment. Eur Psychiatry 2013;28:81-86
17. SU KP, SHEN WW, CHUANG CL, CHEN KP, CHEN CC. A pilot cross-over design study on QTc interval prolongation associated with sulpiride and haloperidol. Schizophr Res 2003;59:93-94
18. VALKONEN-KORHONEN M, TARVAINEN MP, RANTA-AHO P et al. Heart rate variability in acute psychosis. Psychophysiology 2003;40:716-726
19. BäR KJ, LETZSCH A, JOCHUM T, WAGNER G, GREINER W, SAUER H. Loss of efferent vagal activity in acute schizophrenia. J Psychiatr Res 2005;39:519-527
20. CHANG HA, LU RB, LIN WW et al. Lack of association between dopamine D3 receptor Ser9Gly polymorphism and schizophrenia in Han Chinese. Acta Neuropsychiatrica 2007;19:344-350
21. CHANG HA, LU RB, SHY MJ, CHANG CC, LEE MS, HUANG SY. Brain-derived neurotrophic factor Val66Met polymorphism: Association with psychopathological symptoms of schizophreniäJ Neuropsychiatry Clin Neurosci 2009;21:30-37
22. CHANG HA, CHANG CC, CHEN CL et al. Major depression is associated with cardiac autonomic dysregulation. Acta Neuropsychiatrica 2012;24:318-327
23. CHANG HA, CHANG CC, CHEN CL et al. Heart rate variability in patients with fully remitted major depressive disorder. Acta Neuropsychiatrica 2012. DOI:10.1111/j.1601-5215. 2012.00658.x
24. ENDICOTT J, SPITZER RL. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978;35:837-844
25. KAY SR, FISZBEIN A, OPLER LA. The Positive And Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276
26. KUO TB, LIN T, YANG CC, LI CL, CHEN CF, CHOU P. Effect of aging on gender differences in neural control of heart rate. Am J Physiol 1999;277:H2233-H2239
27. LIU CC, KUO TB, YANG CC. Effects of estrogen on genderrelated autonomic differences in humans. Am J Physiol Heart Circ Physiol 2003;285:H2188-H2193
28. ROTTENBERG J. Cardiac vagal control in depression: A critical analysis. Biol Psychol 2007;74:200-211
29. LI Z, SNIEDER H, SU S et al. A longitudinal study in youth of heart rate variability at rest and in response to stress. Int J Psychophysiol 2009;73:212-217
30. MARTIN LA, DOSTER JA, CRITELLI JW et al. Ethnicity and type D personality as predictors of heart rate variability. Int J Psychophysiol 2010;76:118-121
31. AGELINK MW, MAJEWSKI T, WURTHMANN C et al. Effects of newer atypical antipsychotics on autonomic neurocardiac function: A comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol 2001;21:8-13
32. CHANG JS, YOO CS, YI SH et al. Changes in heart rate dynamics of patients with schizophrenia treated with risperidone. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:924-929
33. BäR KJ, WERNICH K, BOETTGER S et al. Relationship between cardiovagal modulation and psychotic state in patients with paranoid schizophrenia. Psychiatry Res 2008;157:255-257
34. MALASPINA D, BRUDER G, DALACK GW et al. Diminished cardiac vagal tone in schizophrenia: Associations to brain laterality and age of onset. Biol Psychiatry 1997;41:612-617
35. POMERANZ B, MACAULAY RJ, CAUDILL MA et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151-H153
36. SLOAN RP, MCCREATH H, TRACEY KJ, SIDNEY S, LIU K, SEEMAN T. RR interval variability is inversely related to inflammatory markers: The CARDIA study. Mol Med 2007;13:178-184
37. MOAK JP, GOLDSTEIN DS, ELDADAH BA et al. Supine lowfrequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. Heart Rhythm 2007;4:1523-1529
38. BAR KJ, KOSCHKE M, BERGER S et al. Influence of olanzapine on QT variability and complexity measures of heart rate in patients with schizophrenia. J Clin Psychopharmacol 2008;28:694-698
39. JINDAL R, MACKENZIE EM, BAKER GB, YERAGANI VK. Cardiac risk and schizophrenia. J Psychiatry Neurosci 2005;30:393-395
40. LOMBARDI F. Clinical implications of present physiological understanding of HRV components. Card Electrophysiol Rev 2002;6:245-249
41. MACKOWIAK M, DUDYS D, CHOCYK A, WEDZONY K. Repeated risperidone treatment increases the expression of NCAM and PSA-NCAM protein in the rat medial prefrontal cortex. Eur Neuropsychopharmacol 2009;19:125-137
42. MCNAMARA RK, ABLE JA, JANDACEK R, RIDER T, TSO P. Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: Evidence for augmented biosynthesis. Schizophr Res 2009;107:150-157
43. JINDAL RD, KESHAVAN MS, EKLUND K, STEVENS A, MONTROSE DM, YERAGANI VK. Beat-To-beat heart rate and QT interval variability in first episode neuroleptic-naive psychosis. Schizophr Res 2009;113:176-180
44. WILLIAMS LM, DAS P, HARRIS AW et al. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry 2004;161:480-489
45. WONG SW, MASSE N, KIMMERLY DS, MENON RS, SHOEMAKER JK. Ventral medial prefrontal cortex and cardiovagal control in conscious humans. Neuroimage 2007;35:698-708
46. ZIEGLER G, DAHNKE R, YERAGANI VK, BAR KJ. The relation of ventromedial prefrontal cortex activity and heart rate fluctuations at rest. Eur J Neurosci 2009;30:2205-2210
47. JENKINS J, SHAJAHAN PM, LAPPIN JM, EBMEIER KP. Right and left prefrontal transcranial magnetic stimulation at 1Hz does not affect mood in healthy volunteers. BMC Psychiatry 2002;2:1
48. GROSSHEINRICH N, RAU A, POGARELL O et al. Theta burst stimulation of the prefrontal cortex: Safety and impact on cognition, mood, and resting electroencephalogram. Biol Psychiatry 2009;65:778-784
49. APPLEBY L, THOMAS S, FERRIER N, LEWIS G, SHAW J, AMOS T. Sudden unexplained death in psychiatric in-patients. Br J Psychiatry 2000;176:405-406
50. RAY WA, CHUNG CP, MURRAY KT, HALL K, STEIN CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009;360:225-235
51. COHEN H, LOEWENTHAL U, MATAR M, KOTLER M. Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-Term psychotropic medication. Br J Psychiatry 2001;179:167-171
52. SILKE B, CAMPBELL C, KING DJ. The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability. J Psychopharmacol 2002;16:355-360
53. WANG YC, YANG CC, BAI YM, KUO TB. Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up. Neuropsychobiology 2008;57:200-205
54. BAR KJ, BOETTGER MK, KOSCHKE M et al. Non-linear complexity measures of heart rate variability in acute schizophrenia. Clin Neurophysiol 2007;118:2009-2015
55. BAR KJ, BOETTGER MK, SCHULZ S et al. The interaction between pupil function and cardiovascular regulation in patients with acute schizophrenia. Clin Neurophysiol 2008;119:2209-2213
56. SATO N, MIYAKE S, AKATSU J, KUMASHIRO M. Power spectral analysis of heart rate variability in healthy young women during the normal menstrual cycle. Psychosom Med 1995;57:331-335